Konrad Aumann

1.7k total citations
41 papers, 731 citations indexed

About

Konrad Aumann is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Konrad Aumann has authored 41 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Genetics and 12 papers in Hematology. Recurrent topics in Konrad Aumann's work include Chronic Lymphocytic Leukemia Research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (6 papers). Konrad Aumann is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (6 papers). Konrad Aumann collaborates with scholars based in Germany, Netherlands and Switzerland. Konrad Aumann's co-authors include Martin Werner, Gian Kayser, Heike L. Pahl, Christine Dierks, Robert Zeiser, Justus Duyster, Dieter Hauschke, Axel zur Hausen, Tilman Brummer and Dietmar Pfeifer and has published in prestigious journals such as Advanced Materials, Circulation and Nature Communications.

In The Last Decade

Konrad Aumann

40 papers receiving 725 citations

Peers

Konrad Aumann
Carrie Brownstein United States
Anil Sadarangani United States
Angela Pennisi United States
Jesse McGreivy United States
Stephen Castaneda United States
Ivan Inigo United States
Carrie Brownstein United States
Konrad Aumann
Citations per year, relative to Konrad Aumann Konrad Aumann (= 1×) peers Carrie Brownstein

Countries citing papers authored by Konrad Aumann

Since Specialization
Citations

This map shows the geographic impact of Konrad Aumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konrad Aumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konrad Aumann more than expected).

Fields of papers citing papers by Konrad Aumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konrad Aumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konrad Aumann. The network helps show where Konrad Aumann may publish in the future.

Co-authorship network of co-authors of Konrad Aumann

This figure shows the co-authorship network connecting the top 25 collaborators of Konrad Aumann. A scholar is included among the top collaborators of Konrad Aumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konrad Aumann. Konrad Aumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Ying, Venugopal R. Mittapalli, Julia Mergner, et al.. (2025). Oncogenic and microenvironmental signals drive cell type specific apoptosis resistance in juvenile myelomonocytic leukemia. Cell Death and Disease. 16(1). 165–165.
2.
Wu, Ying, Geoffroy Andrieux, Konrad Aumann, et al.. (2023). BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia. Leukemia. 38(1). 136–148. 3 indexed citations
3.
Hughes, Amy, Wenbo Yu, Renier Myburgh, et al.. (2021). Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia. Nature Communications. 12(1). 6436–6436. 76 indexed citations
4.
Andrieux, Geoffroy, Franziska Maria Uhl, Michele Proietti, et al.. (2021). Therapeutic targeting of endoplasmic reticulum stress in acute graft-<i>versus</i>-host disease. Haematologica. 107(7). 1538–1554. 5 indexed citations
5.
Beckmann, Matthias W., et al.. (2021). Villoglandular adenocarcinoma of the uterine cervix: a systematic review and meta-analysis. Archives of Gynecology and Obstetrics. 304(2). 317–327. 2 indexed citations
6.
Rawluk, Justyna, Annette Schmitt‐Graeff, Federico Simonetta, et al.. (2020). MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors. JCI Insight. 5(6). 64 indexed citations
7.
Wehrle, Julius, Gabriele Ihorst, Konrad Aumann, et al.. (2020). Prevalence and characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathy. Leukemia Research. 98. 106454–106454. 4 indexed citations
8.
Aumann, Konrad, et al.. (2020). Tumor Handling of Early-stage Cervical Cancer: A Literature Analysis of Villoglandular Adenocarcinoma of the Cervix. Anticancer Research. 40(6). 3049–3053. 2 indexed citations
9.
Jutzi, Jonas S., S Kaiser, Doris Steinemann, et al.. (2019). Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations. Blood. 133(16). 1766–1777. 20 indexed citations
10.
Aumann, Konrad, Ulrich F. Wellner, Peter Bronsert, et al.. (2016). Structured reporting ensures complete content and quick detection of essential data in pathology reports of oncological breast resection specimens. Breast Cancer Research and Treatment. 156(3). 495–500. 22 indexed citations
11.
Hauschke, Dieter, et al.. (2016). Tissue microarray technique is applicable to bone marrow biopsies of myeloproliferative neoplasms. Histochemistry and Cell Biology. 147(1). 75–82. 4 indexed citations
12.
Csanádi, Ágnes, Konrad Aumann, Justyna Rawluk, et al.. (2015). Prognostic Value of Malic Enzyme and ATP-Citrate Lyase in Non-Small Cell Lung Cancer of the Young and the Elderly. PLoS ONE. 10(5). e0126357–e0126357. 31 indexed citations
13.
May, Annette M., Annette Schmitt‐Graeff, Marie Follo, et al.. (2014). Detection of MYD88 L265P mutations in formalin-fixed and decalcified BM biopsies from patients with lymphoplasmacytic lymphoma. Experimental and Molecular Pathology. 97(1). 57–65. 9 indexed citations
14.
Belenki, Dimitri, Konrad Aumann, Dietmar Pfeifer, et al.. (2014). Depletion of STAT5 blocks TEL–SYK-induced APMF-type leukemia with myelofibrosis and myelodysplasia in mice. Blood Cancer Journal. 4(8). e240–e240. 12 indexed citations
15.
Lindner, Silke E., Manuela Wissler, Albert Gründer, et al.. (2013). Increased leukocyte survival and accelerated onset of lymphoma in the absence of MCL-1 S159-phosphorylation. Oncogene. 33(44). 5221–5224. 6 indexed citations
16.
Halbach, Sebastian, Konrad Aumann, Sven Schwemmers, et al.. (2012). Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors. Leukemia. 27(1). 118–129. 42 indexed citations
17.
Aumann, Konrad, Dieter Hauschke, Gian Kayser, et al.. (2012). Template‐based synoptic reports improve the quality of pathology reports of prostatectomy specimens. Histopathology. 60(4). 634–644. 25 indexed citations
18.
Aumann, Konrad, et al.. (2011). Periphere Fazialisparese nach Onyx®-Embolisation einer duralen arteriovenösen Fistel. HNO. 59(5). 465–469. 7 indexed citations
19.
Kayser, Gian, Ahmad Kassem, Wulf Sienel, et al.. (2010). Lactate-Dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1. Diagnostic Pathology. 5(1). 22–22. 64 indexed citations
20.
Aumann, Konrad, et al.. (2009). Pseudomesotheliomatöses Adenokarzinom der Lunge. Der Pathologe. 31(4). 283–289. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026